drug value

Market Access

The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.

Views & Analysis

Addressing the data and evidence gap in the early stages of asset development.

Digital

Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.

Sales & Marketing

The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.